These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23241285)

  • 21. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.
    Cáceres F; Vanotti S; Rao S;
    J Clin Exp Neuropsychol; 2011 Dec; 33(10):1094-8. PubMed ID: 21978317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the incidence and prevalence of cancer in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Trojano M; Sorensen PS; Reingold SC; Cutter G
    Mult Scler; 2015 Mar; 21(3):294-304. PubMed ID: 25533302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary progressive multiple sclerosis: current knowledge and future challenges.
    Rovaris M; Confavreux C; Furlan R; Kappos L; Comi G; Filippi M
    Lancet Neurol; 2006 Apr; 5(4):343-54. PubMed ID: 16545751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy in multiple sclerosis: A nationwide population-based register study.
    Burman J; Zelano J
    Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of metabolic syndrome in Argentina in the last 25 years: systematic review of population observational studies].
    Diaz A; Espeche W; March C; Flores R; Parodi R; Genesio MA; Sabio R; Poppe S
    Hipertens Riesgo Vasc; 2018; 35(2):64-69. PubMed ID: 28927871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.
    Zivadinov R; Iona L; Monti-Bragadin L; Bosco A; Jurjevic A; Taus C; Cazzato G; Zorzon M
    Neuroepidemiology; 2003; 22(1):65-74. PubMed ID: 12566956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological characteristics and functional disability of multiple sclerosis patients in kosovo.
    Zeqiraj K; Kruja J; Kabashi S; Muçaj S
    Med Arch; 2014 Jun; 68(3):178-81. PubMed ID: 25568528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.
    Marrie RA; Reider N; Cohen J; Stuve O; Trojano M; Cutter G; Reingold S; Sorensen PS
    Mult Scler; 2015 Mar; 21(3):318-31. PubMed ID: 25533300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiological aspects of multiple sclerosis in Lublin (Poland)].
    Łobińska A; Stelmasiak Z
    Neurol Neurochir Pol; 2004; 38(5):361-6. PubMed ID: 15565521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review.
    Rojas JI; Patrucco L; Cristiano E
    Degener Neurol Neuromuscul Dis; 2014; 4():103-109. PubMed ID: 32669904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the epidemiology of multiple sclerosis in South America.
    Cristiano E; Patrucco L; Rojas JI
    Eur J Neurol; 2008 Dec; 15(12):1273-8. PubMed ID: 19049543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.
    Marrie RA; Reingold S; Cohen J; Stuve O; Trojano M; Sorensen PS; Cutter G; Reider N
    Mult Scler; 2015 Mar; 21(3):305-17. PubMed ID: 25583845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature.
    Jeong A; Oleske DM; Holman J
    J Child Neurol; 2019 Oct; 34(12):705-712. PubMed ID: 31185780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and prevalence of multiple sclerosis in southeastern Iran.
    Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
    Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low familial risks for multiple sclerosis in Buenos Aires, Argentina.
    Farez MF; Balbuena Aguirre ME; Varela F; Köhler AA; Nagel V; Correale J
    J Neurol Sci; 2014 Nov; 346(1-2):268-70. PubMed ID: 25245176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of multiple sclerosis in the north-west Italian province of Genoa.
    Solaro C; Allemani C; Messmer Uccelli M; Canevari E; Dagnino N; Pizio R; Regesta G; Tanganelli P; Battaglia MA; Mancardi GL
    J Neurol; 2005 Apr; 252(4):436-40. PubMed ID: 15726261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis.
    Harirchian MH; Fatehi F; Sarraf P; Honarvar NM; Bitarafan S
    Mult Scler Relat Disord; 2018 Feb; 20():43-47. PubMed ID: 29291483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.